Iveta Mercep

Zagreb, 10000, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical Practice.

Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical Practice.

Journal: Pharmaceutics

Published: June 06, 2026

Tofersen treatment in SOD1 p.Leu145Phe ALS: real-world outcomes in a genetically homogeneous Croatian cohort.

Tofersen treatment in SOD1 p.Leu145Phe ALS: real-world outcomes in a genetically homogeneous Croatian cohort.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 13, 2026

Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host Disease.

Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host Disease.

Journal: Transplantation and cellular therapy

Published: August 09, 2025

Reshaping Dyslipidaemia Treatment with Bempedoic Acid-A Narrative Review.

Reshaping Dyslipidaemia Treatment with Bempedoic Acid-A Narrative Review.

Journal: Biomedicines

Published: May 14, 2025

PCSK9 inhibition: from effectiveness to cost-effectiveness.

PCSK9 inhibition: from effectiveness to cost-effectiveness.

Journal: Frontiers in cardiovascular medicine

Published: November 16, 2023

Present and Future of Dyslipidaemia Treatment-A Review.

Present and Future of Dyslipidaemia Treatment-A Review.

Journal: Journal of clinical medicine

Published: August 05, 2023

New Therapeutic Approaches in Treatment of Dyslipidaemia-A Narrative Review.

New Therapeutic Approaches in Treatment of Dyslipidaemia-A Narrative Review.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 01, 2022

Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9-A Narrative Review.

Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9-A Narrative Review.

Journal: Cardiovascular therapeutics

Published: December 15, 2021

Prophylactic therapeutic plasma exchange in pregnant woman with Familial Chylomicronemia Syndrome - A case report.

Prophylactic therapeutic plasma exchange in pregnant woman with Familial Chylomicronemia Syndrome - A case report.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: September 28, 2021

Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.

Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.

Journal: European journal of clinical pharmacology

Published: June 23, 2021

Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.

Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.

Journal: Croatian medical journal

Published: May 08, 2020

Resolving Issues About Efficacy and Safety of Low-Dose Codeine in Combination Analgesic Drugs: A Systematic Review.

Resolving Issues About Efficacy and Safety of Low-Dose Codeine in Combination Analgesic Drugs: A Systematic Review.

Journal: Pain and therapy

Published: February 02, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026